Medicilon Logo
|
search icon search icon language icon contact icon menu icon
Medicilon Logo
|
search icon close search icon language icon contact icon menu icon
logo icon CN
Contact Us
Close Button
Message
Back To Top
Online Message×
Click switch
Close Button
Medicilon's News information
News information

Join Medicilon at ACS Fall 2022

2022-08-10
|
Page View:

Medicilon-2022-ACS-Fall1.jpg

We are pleased to announce that Medicilon will participate in the American Chemical Society's Fall Annual Meeting, which kicks off on August 21st, 2022. Our US team will be around throughout the event. Welcome to stop by and chat with us at booth #325. We look forward to seeing you!


Organizer: ACS

Date: August 21 - 25, 2022

Location: Chicago, IL & Hybrid

 

About ACS Fall 2022

Chartered by the United States Congress in 1876, ACS is the world's largest scientific society to advance the broader chemical enterprise and its practitioners to improve people's lives through the transformational power of chemistry. ACS provides information, education, careers and more in chemistry and related fields to help its members and scientists thrive in a changing global economy.

 

About Medicilon

Medicilon is an integrated preclinical contract research organization (CRO) providing comprehensive drug research and development services to pharmaceutical and biotech companies as well as academic and government research institutions worldwide. With 18+ years of experiences, 700,000+ ft2 of research facilities, and innovated technology platforms, we provide customized R&D solutions ranging from precise drug targeting to IND filing assistance.

 

Medicilon Drug Discovery Services

Medicilon Drug discovery services include chemistry (synthetic chemistry, medicinal chemistry) and biology. In terms of chemistry, it can undertake multi-dimensional business such as custom synthesis, compound library construction, SAR compound synthesis and screening, compound structure and biological activity optimization.


The medicinal chemistry team deeply cross-integrates chemistry and biology into each project, and flexibly uses the powerful expertise of computational chemistry to aid the compound design process. At the same time, Medicilon extensively uses advanced drug discovery technology, including PROTAC targeted protein degradation technology, DEL DNA-encoded small molecule compound library screening technology, ADC antibody drug conjugation technology, etc. Medicilon efficiently promotes customers' drug research and development projects, controls costs, and improves quality!

 

Medicilon’s Medicinal Chemistry Services

Our medicinal chemistry team is capable of flexibly applying computer chemistry to assist compound design process. We are also proud of our rich experience in innovative design and patent strategies that complement our technologies. In addition, our responsive project management and effective communication help optimize our project delivery.

 Feasibility assessment of new drug targets

 High-throughput screening and discovery of active compounds based on structural design

 SAR-based compound synthesis and SAR-based optimization

 Establishment of specific compound libraries (establishment of micromolecule compound library)

 Rapid synthesis of PROTAC molecules and ADC payloads, as well as lipids, glycolipids, and phospholipids

 Screening of new hit compounds from DEL (from active compounds to discovery of lead compounds)

 Synthesis, discovery, and optimization of hit compounds

 Research on SAR

 Computer-aided drug design (CADD)

 Processes from optimization of lead compounds to determination of preclinical drug candidates

 Patent preparation and application

 ELN system records

 Multi-parameter lead optimization for desired target molecule profiles (synthesis, discovery, and structural optimization of lead compounds)


Share:
Relevant newsRelevant news